April 19, 2018 8:27 PM ET


Company Overview of IDUN Pharmaceuticals, Inc.

Key Executives for IDUN Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Willis C. Maddrey M.D., M.A.C.P., FRCP London6 RelationshipsSenior Medical Advisor--
Paul J. Pockros M.D.14 RelationshipsSenior Medical Advisor--

IDUN Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ronald J. Saldarini Ph.D. 36 RelationshipsQuill Medical, Inc.77
Anthony B. Evnin 122 RelationshipsVenrock76
Daniel R. Omstead M.S, Ph.D. 82 RelationshipsTekla Healthcare Investors64
Hermann Steller Ph.D. 5 RelationshipsIDUN Pharmaceuticals, Inc.--
Stanley J. Korsmeyer M.d. 5 RelationshipsDana-Farber Cancer Institute, Inc.--
View All Board Members

IDUN Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
IDUN Pharmaceuticals, Inc. CEO Compensation
Industry Average


Phylogica Announces Management Changes
April 10, 2018 11:43 PM ET
Rosetta Genomics Ltd. Announces Resignation of Ken Berlin as President and CEO, Effective April 18, 2018
April 10, 2018 8:04 PM ET
ReNeuron Group plc Announces Executive Changes
April 10, 2018 12:00 PM ET
ProQR Therapeutics N.V. Appoints Dr. Peter A. Beal to Scientific Advisory Board
April 10, 2018 11:00 AM ET
Collagen Solutions plc Appoints Louis T. Ruggiero as Chief Business Officer effective as of 16 April 2018
April 10, 2018 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IDUN Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.